First Report of Successful Rituximab Therapy in Idiopathic Sclerosing Mesenteritis
{{output}}
Sclerosing mesenteritis (SM) is a rare idiopathic fibroinflammatory disorder of the bowel mesentery adipose tissue. While the use of rituximab has been documented in IgG4-related SM, its effectiveness in idiopathic, IgG4-unrelated SM remains unknown. We presen... ...
